Tumor necrosis factor-α inhibitors and their effects on cardiovascular risk factorsin patients with rheumatoid arthritis
Main Authors: | O G Lineva, T V Popkova, D S Novikova, E L Nasonov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2010-02-01
|
Series: | Научно-практическая ревматология |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/1240 |
Similar Items
-
Ihmor necrosis factor-a inhibitors and cardiovascular risk in rheumatoid arthritis
by: Tatiana Valentinovna Popkova, et al.
Published: (2012-12-01) -
Prophylaxis of cardiovascular diseases in rheumatoid arthritis
by: D S Novikova, et al.
Published: (2009-05-01) -
CARDIOVASCULAR DISEASES IN RHEUMATOID ARTHRITIS: LATEST DATA
by: T. V. Popkova, et al.
Published: (2016-07-01) -
Interleukin-6 inhibition and cardiovascular disease in patients with rheumatoid arthritis
by: T V Popkova, et al.
Published: (2016-05-01) -
Reduction of cardiovascular risk in rheumatoid arthritis: double benefit of statins
by: Diana Sergeevna Novikova, et al.
Published: (2010-12-01)